The new Regulation establishes more detailed and stringent evaluation criteria, aimed at ensuring maximum transparency and reliability.
Among the new requirements are specific criteria for:
- technical documentation
- a Quality Management System for manufacturers
- a thorough review of clinical evaluations, with particular emphasis on quality.
Additionally, post-market surveillance is implemented, ensuring that product monitoring is continuous and proactive.